arrow
E

Emilio Portaccio

University of Florence
H指数:58
被引数:1.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Diagnostic value of the kappa free light chain index in multiple sclerosis under the 2024 CSF positivity criterion: a multicentre study in oligoclonal band-negative patients

2024年脑脊液阳性标准下κ游离轻链指数在多发性硬化中的诊断价值:一项在寡克隆带阴性患者中的多中心研究

2026-11-080
OA
Validation of generative artificial intelligence techniques for synthetic data generation in multiple sclerosis research: A comparison with real-world evidence from the Italian multiple sclerosis registry

生成式人工智能技术在多发性硬化症研究中合成数据生成中的验证:与意大利多发性硬化症登记处真实世界证据的比较

2026-10-140
PRE
HerMeS: a registry-based evaluation of the HERCULES criteria for identifying nonrelapsing SPMS

HerMeS:一项基于注册研究的HERCULES标准评估,用于识别非复发型SPMS

2026-03-090
OAAI
Pediatric, adult, and late onset multiple sclerosis: Cognitive phenotypes and gray matter atrophy

小儿,成人和迟发性多发性硬化症: 认知表型和灰质萎缩

2025-01-240
OA
Home-based, computer-assisted cognitive rehabilitation for attention in pediatric onset multiple sclerosis: a randomized, multicenter pilot study

居家计算机辅助注意力认知康复在儿童期发病多发性硬化中的应用:一项随机、多中心试点研究

2024-11-250
PRE
A comparison of natalizumab and ocrelizumab on disease progression in multiple sclerosis

那他珠单抗和ocrelizumab对多发性硬化疾病进展的比较

2024-07-053
OA
Disease-modifying therapies in managing disability worsening in paediatric-onset multiple sclerosis: a longitudinal analysis of global and national registries

控制小儿多发性硬化症患者残疾恶化的疾病改善疗法: 全球和国家注册机构的纵向分析

2024-05-014
PRE
Impact of COVID-19 on pregnancy and fetal outcomes in women with multiple sclerosis

新型冠状病毒肺炎对多发性硬化妇女妊娠和胎儿结局的影响

2024-03-081
OA